Literature DB >> 26314775

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

K Fizazi1, F A Greco2, N Pavlidis3, G Daugaard4, K Oien5, G Pentheroudakis3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26314775     DOI： 10.1093/annonc/mdv305

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  68 in total

Review 1.  Progress in refining the clinical management of cancer of unknown primary in the molecular era.

Authors:  Elie Rassy; Nicholas Pavlidis
Journal:  Nat Rev Clin Oncol       Date:  2020-04-29       Impact factor: 66.675

2.  Combined p16 and p53 expression in cervical cancer of unknown primary and other prognostic parameters : A single-center analysis.

Authors:  Müjdat Yildirim; Jens Müller von der Grün; Ria Winkelmann; Emmanouil Fokas; Franz Rödel; Hanns Ackermann; Claus Rödel; Panagiotis Balermpas
Journal:  Strahlenther Onkol       Date:  2017-01-31       Impact factor: 3.621

3.  Mechanism of early dissemination and metastasis in Her2+ mammary cancer.

Authors:  Kathryn L Harper; Maria Soledad Sosa; David Entenberg; Hedayatollah Hosseini; Julie F Cheung; Rita Nobre; Alvaro Avivar-Valderas; Chandandaneep Nagi; Nomeda Girnius; Roger J Davis; Eduardo F Farias; John Condeelis; Christoph A Klein; Julio A Aguirre-Ghiso
Journal:  Nature       Date:  2016-12-14       Impact factor: 49.962

4.  Molecular Profiles of Brain and Pulmonary Metastatic Disease in Cancer of Unknown Primary.

Authors:  Brianna R Bakow; Christopher P Elco; Mark LeGolvan; Don Dizon; Thomas A Ollila
Journal:  Oncologist       Date:  2020-04-20

5.  Impact of PET/CT on clinical management in patients with cancer of unknown primary-a PET/CT registry study.

Authors:  Christian Philipp Reinert; Julia Sekler; Christian la Fougère; Christina Pfannenberg; Sergios Gatidis
Journal:  Eur Radiol       Date:  2019-11-14       Impact factor: 5.315

6.  Nationwide survey on family caregiver-perceived experiences of patients with cancer of unknown primary site.

Authors:  Kyoko Ishida; Kazuki Sato; Hirokazu Komatsu; Tatsuya Morita; Tatsuo Akechi; Megumi Uchida; Kento Masukawa; Naoko Igarashi; Yoshiyuki Kizawa; Satoru Tsuneto; Yasuo Shima; Mitsunori Miyashita; Shoko Ando
Journal:  Support Care Cancer       Date:  2022-04-28       Impact factor: 3.603

Review 7.  Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary.

Authors:  Sebastián Moran; Anna Martinez-Cardús; Stergios Boussios; Manel Esteller
Journal:  Nat Rev Clin Oncol       Date:  2017-07-04       Impact factor: 66.675

Review 8.  Cancer of Unknown Primary in the Molecular Era.

Authors:  Shumei Kato; Ahmed Alsafar; Vighnesh Walavalkar; John Hainsworth; Razelle Kurzrock
Journal:  Trends Cancer       Date:  2021-01-28

9.  A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.

Authors:  Holger Moch; Alwin Krämer; Chantal Pauli; Tilmann Bochtler; Linda Mileshkin; Giulia Baciarello; Ferran Losa; Jeffrey S Ross; George Pentheroudakis; George Zarkavelis; Suayib Yalcin; Mustafa Özgüroğlu; Andreas Beringer; Jeremy Scarato; Mathis Mueller-Ohldach; Marlene Thomas
Journal:  Oncologist       Date:  2021-03-25

10.  Response to "The need for validation of MI GPSai in patients with CUP: Comment on: "Machine learning analysis using 77,044 genomic and transcriptomic profiles to accurately predict tumor type" by J Abraham et al."

Authors:  Jim Abraham; Chadi Nabhan; Matthew Oberley; Wolfgang Michael Korn; David Spetzler
Journal:  Transl Oncol       Date:  2021-08       Impact factor: 4.243
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.